A Review on major Bioactivities of Bacopa monnieri

  • Gayatri Kishanprasad Pushkar University of Mumbai
  • Bhupendra K. Pushkar University of Mumbai
  • Rohini Sivabalan Ramnarain Ruia College, University of Mumbai
Keywords: Bacopa monnieri, Brahmi, Scrophulariaceae

Abstract

 Bacopa monnieri (family: Scrophulariaceae) is a reputed drug of Ayurveda. It is used in traditional medicine to treat various nervous disorders and for promoting memory and intellect. This medicinal plant is locally known as Brahmi. It is known as a memory enhancer and many preparations of brahmi are now commercially available in the market. Herbal medicines are gaining importance hence B. monnieri has been studied extensively for its chemical constituents, constituents responsible for memory enhancing  effect and also its various other useful effects. As now a days natural products are much preferred so the possible use of brahmi as a neuropsycotropic drug is also gaining importance. Some of its effects has been established in several in vivo and in vitro models. This article reviews the useful effects of this plant.

Author Biographies

Gayatri Kishanprasad Pushkar, University of Mumbai
Phd student, Dept of Zoology, Ramnarian Ruia college
Bhupendra K. Pushkar, University of Mumbai
H.O.D., Department of Biotechnology
Rohini Sivabalan, Ramnarain Ruia College, University of Mumbai
Adjunct Professor, Department of Zoology 

References

1.W.H.O., Traditional Medicine, Fact Sheet, World Health Organization, Geneva, Switzerland, no. 134, 2003.

2. Kashmira J Gohil, Jagruti A Patel “A review on Bacopa monniera: Current research and future prospects” Maliba Pharmacy College, Bardoli, Surat, Gujarat, India, Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, India.

3.Mukheijee DG, Dey CD. Clinical trial on Brahmi. Int J Exp Med Sci 1966;10:5-11.

4.Chopra RN. Indigenous Drugs of India. 2nd ed. Calcutta, India: U.N. Dhur and Sons; 1958. p. 341.

5.Nadkarni KM. The Indian Materia Medica. Columbia, MO: South Asia Books; 1988. p. 624-25.

6.Kirtikar KR, Basu BD. Indian Medicinal Plants, part II. Allahabad: Indian Press; 1918. p. 930-1.

7.Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomed 2005;12:305-17.

8.Satyavati GV, Raina MK, Sharma M. Medicinal Plants of India. Vol 1. New Delhi: Ind Council Med Res; 1976. p. 112-8.

9. Srinivasa Rao Bammidi , Sharan Suresh Volluri , Seema Chaitanya Chippada , Sumanjali Avanigadda , Meena Vangalapati “A Review on Pharmacological Studies of Bacopa monniera” Journal of Chemical, Biological and Physical Sciences.

10.Chopra RN, Nayar L, Chopra IC. Glossary of Indian Medicinal Plants, vol. 32. Council of Scientific and Industrial Research, New Delhi: 1956.

11.Shastri MS, Dhalla NS, Malhotra CL. Chemical investigation of Herpestis monniera Linn (Brahmi). Ind J Pharmacol 1959;21:303-4.

12.Chatterji N, Rastogi RP, Dhar ML. Chemical examination of Bacopa monniera Wettst: part II -isolation of chemical constituents. Ind J Chem 1965;3:24-9.

13.Rastogi RP. Compendium of Indian Medicinal Plants. Vol 1. New Delhi: CSIR; 1990. p. 118-22.

14.Kulshreshtha DK, Rastogi P, Bacogenin A1: a novel dammerane triterpene sapogenin from Bacopa monniera. Phytochem 1973;12:887-92.

15.Kulshreshtha DK, Rastogi RP. Bacogenin A2: a new sapogenin from bacosides. Phytochem 1973;13:1205-6.

16.Chandel RS, Kulshreshtha DK, Rastogi RP. Bacogenin A3: a new sapogenin from Bacopa monniera. Phytochem 1977;16:141-3.

17.Rastogi S, Pal R, Kulshreshtha DK. Bacoside A3-a triterpenoid saponin from Bacopa monniera. Phytochem 1994;36:133-7.

18.Garay S, Mahato SB, Ohtani K, Yamasaki K. Dammarane-type triterpenoid saponins from Bacopa monniera. Phytochem 1996;42:815-20.

19.Chakravarty AK, Sarkar T, Masuda K, Shiojima K, Nakane T, Kawahara N. Bacopa side I and II: two pseudojujubogenin glycosides from Bacopa monniera. Phytochem 2001;58:553-6.

20.Chakravarty AK, Garai S, Masuda K, Nakane T, Kawahara, N. Bacopasides III-V: three new triterpenoid glycosides from Bacopa monniera. Chem Pharm Bull 2003;51:215-7.

21.Chakravarty AK, Sarkar T, Nakane T, Kawahara N, Masuda K. New phenylethanoid glycosides from Bacopa monniera. Chem Pharm Bull 2002;50:1616-8. [PUBMED] [FULLTEXT]


22.Hou CC, Lin SJ, Cheng JT, Hsu FL. Bacopaside III, bacopasaponin G, and bacopasides A, B, and C from Bacopa monniera. J Nat Prod 2002;65:1759-63. [PUBMED] [FULLTEXT]

23.Deepak M. The need for establishing identities of `bacoside A and B? The putative major bioactive saponins of Indian medicinal plant. Phytomed 2003;11:264-8.

24.Singh HK, Rastogi RP, Srimal RC, Dhawan BN. Effect of bacosides A and B on avoidance responses in rats. Phytother Res 1988;2:70-5.

25.Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Ind J Pharmacol 1997;29:S359-S65.

26. Srinivasa Rao Bammidi , Sharan Suresh Volluri , Seema Chaitanya Chippada , Sumanjali Avanigadda , Meena Vangalapati “A Review on Pharmacological Studies of Bacopa monniera” Journal of Chemical, Biological and Physical Sciences.

27. Nestler Eric J, Michel Barrot, Ralph J DiLeone Amelia J. Eisch, Stephen J. Gold, Lisa M. Monteggia. Neurobiology of Depression. Neuron.2002; 34: 13–25.

28. Kashmira J Gohil, Jagruti A Patel “A review on Bacopa monniera: Current research and future prospects” Maliba Pharmacy College, Bardoli, Surat, Gujarat, India, Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, India.

29.Shader RI, Greenblatt DJ. Pharmacotherapy of acute anxiety. In: Bloom FE, Kupfer DJ. editors. Psycopharmacology: Fourth generation of progress. New York: Raven Press; 1995. p. 1341-8.

30.Singh RH, Singh L. Studies on the anti-anxiety effect of the Medyha Rasayana drug, Brahmi (Bacopa monniera Wettst.) - Part 1. J Res Ayur Siddha 1980;1:133¬-48.

31.Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive Performance, anxiety, and depression in the Elderly: A randomized, double-Blind, placebo-controlled trial. J Alt Comp Med 2008;14:707-13.

32. Khan R, Krishnakumar A, Paulose CS. Decreased glutamate receptor binding and NMDA R1 gene expression in hippocampus of pilocarpine-induced epileptic rats: neuroprotective role of Bacopa monnieri extract. Epilepsy and Behav 2008;12:54-60.

33.Martis G, Rao A, Karanth KS. Neuropharmacological activity of Herpestis monniera. Fitoterapia 1992;63:399-404.

34.Ganguly DK, Malhotra CL. Some behavioural effects of an active fraction from Herpestis monniera, Linn. (Brahmi). Ind J Med Res 1967;55:473-82.

35. Paulose CS, Chathu F, Khan SR, Krishnakumar A. Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression.Molecular Neurobiology and Cell Biology Unit, Centre for Neuroscience, Department of Biotechnology, Cochin University of Science and Technology.

36. Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HK. Adaptogenic effect of Bacopa monniera (Brahmi). Division of Pharmacology, Central Drug Research Institute, Chattar Manzil Palace, Lucknow, India.Pharmacology, Biochemistry, and Behavior [2003, 75(4):823-830]

37.Singh S, Eapen S, D'Souza SF. Cadmium accumulation and its influence on lipid peroxidation and antioxidative system in an aquatic plant, Bacopa monnieri L. Chemosphere 2006;62:233-46. [PUBMED] [FULLTEXT]

38.Bafna PA, Balaraman R. Antioxidant activity of DHC-1, an herbal formulation, in experimentally-induced cardiac and renal damage. Phytother Res 2005;19:216-21. [PUBMED] [FULLTEXT]

39.Sumathy T, Govindasamy S, Balakrishna K, Veluchamy G. Protective role of Bacopa monniera on morphine-induced brain mitochondrial enzyme activity in rats. Fitoterapia 2002;73:381-5. [PUBMED] [FULLTEXT]

40.Pawar R, Gopalakrishnan C, Bhutani KK. Dammarane triterpene saponin from Bacopa monniera as the superoxide inhibitor in polymorphonuclear cells. Planta Med 2001;67:752-4. [PUBMED] [FULLTEXT]

41.Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP. Bacopa monniera Linn. as an antioxidant: mechanism of action. Ind J Exp Biol 1996;34:523-6.

42.Kapoor KR, Srivastava SS, Kakkar P. Bacopa monnieri modulates antioxidant responses in brain and kidney of diabetic rats. Environ Toxicol Pharmacol 2008 (article in press).

43.Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN. Screening of Indian plants for biological activity: Part II. Ind J Exp Biol 1969;7:250-62.

44.Singh HK, Shanker G, Patnaik GK. Neuropharmacological and anti-stress effects of bacosides: a memory enhancer. Ind J Pharmacol 1996;28:47.

45.Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum, and hippocampus. Phytother Res 2000;14:174-9. [PUBMED] [FULLTEXT]

46.Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant approach to disease management and the role of 'Rasayana' herbs. Ayur J Ethnopharmacol 2005;99:165-78.

47.Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res 2002;16:639-45. [PUBMED] [FULLTEXT]

48.Rohini, G, Sabitha, KE., Devi, CS. Bacopa monniera Linn. extract modulates antioxidant and marker enzyme status in fibrosarcoma bearing rats. Ind J Exp Biol 2004;42:776-80.

49.Seiss H. Strategies of antioxidant defence. Eur J Biochem 1993;215:213-9.

50.Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh H. Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacol Biochem Behav 2003;75:823-30.

51.Jyoti A, Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicol 2006;27:451-7.

52.Vijayan VA, Helen A. Protective activity of Bacopa monniera Linn. On nicotine-induced toxicity in mice. Phytother Res 2007;21:378-81.

53.Holcomb LA, Dhanasekaran M, Hitt AR, Young KA, Riggs M, Manyam BV. Bacopa monniera extract reduces amyloid levels in PSAPP mice. J Alzheimers Dis 2006;9:243-51. [PUBMED] [FULLTEXT]

54.Anbarasi K, Vani G, Balakrishna K, Devi CS. Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci 2006;78:1378-84. [PUBMED] [FULLTEXT]

55.Aloe A, Alleve E, Fiore M. Stress and nerve growth factor findings in animal models and humans. Pharmacol Biochem Behav 2002;73:159-66.

56.Sairam K, Rao CV, Babu MD, Goel RK. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomed 2001;8:423-30.

57.Dorababu M, Prabha,T, Priyambada S, Agrawal VK, Aryya NC, Goel RK. Effect of Bacopa monniera and Azadirachta indica on gastric ulceration and healing in experimental NIDDM rats. Ind J Exp Biol 2004;42:389-97.

58.Jain P, Khanna NK, Trehan T, Pendse VK, Godhwani JL. Anti-inflammatory effects of an Ayurvedic preparation, Brahmi Rasayan, in rodents. Ind J Exp Biol 1994;32:633-6.

59.Rao CH, Sairam K, Goel RK. Experimental evaluation of Bacopa monniera on rat gastric ulceration and secretion. Ind J Physiol Pharmacol 2000;44:435-41.

60.Dharmani P, Palit G. Exploring Indian medicinal plants for antiulcer activity. Ind J Pharmacol 2006;38:95-9.

61.Goel RK, Sairam K. Anti ulcer drugs from indigenous sources with emphasis on Musa sapientum, tamrabhasma, Asparagus racemosus and zinzibar officinale. Ind J Pharmacol 2002;34:100-10.

62.Goel RK, Sairam K, Babu MD, Tavares IA, Raman A. In vitro evaluation of Bacopa monniera on anti- Helicobacter pylori activity and accumulation of prostaglandins. Phytomed 2003;10:523-7.

63.Malhotra CK, Das PK. Pharmacological studies of Herpestis monniera Linn (Brahmi). Ind J Med Res 1959;47:294-305.

64.Aithal HN, Sirsi M. Pharmacological investigation on Herpestis monniera. Ind J Pharmacy 1961;23:2-5.

65.Prakash JC, Sirsi M. Comparative study of the effects of brahmi (Bacopa monniera) and chlorpromazine on learning in rats. J Sci Indust Res 1962;21:93-6.

66.Sinha MM. Some empirical behavioural data indicative of concomitant biochemical reactions. Proceeds Ind. Sci. Congress Part II, Bangalore: 1971. p. 1-26.

67.Sternberg, R. J., & Sternberg, K. (2009). Cognitive psychology (6th Ed.). Belmont, CA: Wadsworth, Cengage Learning.

68. Tatimah Peth-Nui, Jintanaporn Wattanathorn, Supaporn Muchimapura, Terdthai Tong-Un, Nawanant Piyavhatkul, Poonsri Rangseekajee, Kornkanok Ingkaninan, and Sakchai Vittaya-areekul “Effects of 12-Week Bacopa monnieri Consumption on Attention, Cognitive Processing, Working Memory, and Functions of Both Cholinergic and Monoaminergic Systems in Healthy Elderly Volunteers”

69.Bhattacharya SK, Kumar A, Ghosal S. Effect of Bacopa monniera on animal models of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. In: DV Siva Sankar, editors. Molecular Aspects of Asian Medicines. New York: PJD Publications; 1999. p. 27-58.

70.Singh HK, Dhawan BN. Effect of Bacopa monnieri Linn. (Brahmi) extract on avoidance responses in rat. J Ethnopharmacol 1982;5:205-8. [PUBMED] [FULLTEXT]

71.Singh HK, Rastogi RP, Srimal RC, Dhawan BN. Effect of bacosides A and B on avoidance responses in rats. Phytother Res 1988;2:70-5.

72.Sairam K, Rao CV, Babu MD, Goel RK. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomed 2001;8:423-30.

73.Roodenrys A, Booth D, Bulzomi A, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacol 2002;27:279-81.

74.Nathan PJ, Clarke J, Lloyd J, Hutchison CW, Downey L, Stough C. The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects. Hum Psychopharmacol 2001;16:345-51.

75.Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, et al. The chronic effects of an extract of Bacopa monniera(Brahmi) on cognitive function in healthy human subjects. Psychopharmacol 2001;156:481-4.

76.Sharma R, Chaturvedi C, Tewari PV. Efficacy of Bacopa monnieri in revitalizing intellectual functions in children. J Res Edu Ind Med 1987;1:1-12.

77.Negi KS, Singh YD, Kushwaha KP, Rastogi CK, Rathi AK, Srivastava JS, et al. Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder. Ind J Psychiatry 2000;42:Supplement.

78.Raghav S, Singh RS, Dalal H, Srivastava PK, Asthana JS. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Ind J Psychiatry 2006;48:238-42.

79.Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Ind J Pharmacol 1997;29:S359-S65.


80.Martis G, Rao A, Karanth KS. Neuropharmacological activity of Herpestis monniera. Fitoterapia 1992;63:399-404.

81.Russo A, Borrelli F, Campisi A, Acquaviva R, Raciti G, Vanella A. Nitric oxide-related toxicity in cultured astrocytes: Effect of Bacopa monniera. Life Sci 2003;73:1517-26. [PUBMED] [FULLTEXT]

82.Russo A, Izzo AA, Borrelli F, Renis M, Vanella A. Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother Res 2003;17:870-5. [PUBMED] [FULLTEXT]

83.Elangovan V, Govindasamy S, Ramamoorthy N, Balasubramaanian K. In vitro studies on the anticancer activity of Bacopa monnieri. Fitoterapia 1995;66:211-5.

84.Kar A, Panda S, Bharti S. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol 2002;81:281-5. [PUBMED]

85.Channa S, Dar A, Anjum S, Yaqoob M, Rahman A. Anti-inflammatory activity of Bacopa monniera in rodents. J Ethnopharmacol 2006;104:286-9.

86.Jain P, Khanna NK, Trehan T, Pendse VK, Godhwani JL. Anti-inflammatory effects of an Ayurvedic preparation, Brahmi Rasayan, in rodents. Ind J Exp Biol 1994;32:633-6.

87.Dar A, Channa S. Calcium antagonistic activity of Bacopa monniera on vascular and intestinal smooth muscles of rabbit and guinea-pig. J Ethnopharmacol 1999;66:167-74. [PUBMED] [FULLTEXT]

88.Channa S, Dar A, Anjum S, Yaqoob M, Rahman A. Anti-inflammatory activity of Bacopa monniera in rodents. J Ethnopharmacol 2006;104:286-9.

89.Channa S, Dar A, Yaqoob M, Anjum S, Sultani Z, Rahman A. Bronchovasodilatory activity of fractions and pure constituents isolated from Bacopa monniera. J Ethnopharmacol 2003;86:27-35.

90.Samiulla DS, Prashanth D, Amit A. Mast cell stabilizing activity of Bacopa monnieri. Fitoterapia 2001;72:284-5. [PUBMED] [FULLTEXT]

91.Sumathy T, Subramanian S, Govindasamy S, Balakrishna K, Veluchamy G. Protective role of Bacopa monniera on morphine induced hepatotoxicity in rats. Phytother Res 2001;15:643-5.

92.Smith DB. Cognitive effects of anti-epileptic drugs. Adv Neurol 1991;55:197-212.

93.Vohora D, Pal SN, Pillai KK. Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant. J Ethnopharmacol 2000;71:383-90. [PUBMED] [FULLTEXT]

94.Prakash JC, Sirsi M. Comparative study of the effects of brahmi (Bacopa monniera) and chlorpromazine on learning in rats. J Sci Indust Res 1962;21:93-6.

95.Ganguly DK, Malhotra CL. Some behavioural effects of an active fraction from Herpestis monniera, Linn. (Brahmi). Ind J Med Res 1967;55:473-82.

96. N.Sheikh, A. Ahmad, K. B. Siripurapu, V.K. Kuchibhotla, S. Singh, G. Palit, J Ethnopharmcol,2007,111:671

97.Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-503. [PUBMED] [FULLTEXT]

98. Russo A, Borrelli F, Bacopa monniera, a reputed nootropic plant,An overview,Phytomedicine, 12(4):305-317, 2005.

99. A. Anand, M. K. Saraf, S. Prabhakar, and K. L. Khanduja, “Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice,” Evidence-basedComplemen- tary and Alternative Medicine, vol. 2011, Article ID 236186, 10 pages, 2011.

100. N.Uabundit,J.Wattanathorn,S.Mucimapura,andK.Ingkan- inan, “Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model,” Journal of Ethnopharmacology, vol. 127, no. 1, pp. 26–31, 2010.

101. H. Joshi and M. Parle, “Brahmi rasayana improves learning and memory in mice,” Evidence-based Complementary and Alternative Medicine, vol. 3, no. 1, pp. 79–85, 2006.

102 S. Raghav, H. Singh, P. K. Dalal, J. S. Srivastava, and O. P. Asthana,“RandomizedcontrolledtrialofstandardizedBacopa monniera extract in age-associated memory impairment,” Indian Journal of Psychiatry, vol. 48, no. 4, pp. 238–242, 2006.

103. M. P. Pase, J. Kean, J. Sarris, C. Neale, A. B. Scholey, and C. Stough, “The cognitive-enhancing effects of Bacopa mon- nieri: a systematic review of randomized, controlled human clinical trials,” The Journal of Alternative and Complementary Medicine, vol. 18, no. 7, pp. 647–652, 2012.

104. G. Martis, A. Rao, and K. S. Karanth, “Neuropharmacological activity of Herpestis monniera,” Fitoterapia, vol. 63, no. 5, pp. 399–404, 1992.
Published
2015-03-29
Section
Review Articles